Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 407

    Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

    Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

    supriya kashyap kashyap8 July 2017 9:16 AM IST
    Princeton : Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) has approved ORENCIA for the treatment of adults with...
    Novo Nordisk recalls faulty cartridge holders in insulin pens

    Novo Nordisk recalls faulty cartridge holders in insulin pens

    Ruby Khatun Khatun8 July 2017 9:00 AM IST
    Danish drugmaker Novo Nordisk said on Wednesday it was initiating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices...
    Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

    Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

    Ruby Khatun Khatun7 July 2017 1:24 PM IST
    Sanofi and Regeneron Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the...
    Jubilant Life Sciences gets USFDA nod for anti-depressive drug

    Jubilant Life Sciences gets USFDA nod for anti-depressive drug

    Ruby Khatun Khatun7 July 2017 1:19 PM IST
    New Delhi: Drug firm Jubilant Life Sciences said its subsidiary has received final approval from the US health regulator for Bupropion Hydrochloride...
    Samsung to offer free of cost equipment to select govt hospitals in Tamil Nadu

    Samsung to offer free of cost equipment to select govt hospitals in Tamil Nadu

    Ruby Khatun Khatun7 July 2017 1:18 PM IST
    Chennai: Korean electronics major Samsung launched in Tamil Nadu its Smart Healthcare programme under which advanced equipment manufactured by it are...
    Open to changes in new standards for food supplements: FSSAI

    Open to changes in new standards for food supplements: FSSAI

    Ruby Khatun Khatun7 July 2017 9:19 AM IST
    New Delhi: Food regulator FSSAI on Thursday assured the food supplements and nutraceuticals industry that it is open to making changes in the new...
    Reckitt Benckiser cuts sales forecast after cyber attack

    Reckitt Benckiser cuts sales forecast after cyber attack

    Ruby Khatun Khatun7 July 2017 9:13 AM IST
    LONDON: British consumer goods maker Reckitt Benckiser trimmed its sales forecasts on Thursday, becoming one of the first companies to put a cost on a...
    Narayana Health plans to expand in Maharashtra

    Narayana Health plans to expand in Maharashtra

    Ruby Khatun Khatun6 July 2017 1:07 PM IST
    Mumbai: As part of its growth plans, multi-speciality hospital chain Narayana Health is now looking at expanding in Maharashtra after commencing...
    Shantha Biotechnics cholera vaccine, Shanchol achieves 10 million doses milestone

    Shantha Biotechnics cholera vaccine, Shanchol achieves 10 million doses milestone

    Ruby Khatun Khatun6 July 2017 1:03 PM IST
    Hyderabad: Shantha Biotechnics, the Hyderabad-based affiliate of Sanofi Pasteur (the vaccines division of Sanofi), said it has delivered 10 million...
    Zydus Cadila starts phase II trials of molecule targeting anaemia

    Zydus Cadila starts phase II trials of molecule targeting anaemia

    Ruby Khatun Khatun6 July 2017 1:01 PM IST
    New Delhi: Drug firm Zydus Cadila on Wednesday announced the initiation of a phase II trial of oral small molecule Zyan1 that has been designed for...
    Granules India gets board nod to raise foreign limit to 49 percent

    Granules India gets board nod to raise foreign limit to 49 percent

    Ruby Khatun Khatun6 July 2017 1:00 PM IST
    New Delhi: Drug firm Granules India on Wednesday said its board has approved a proposal to increase the foreign investment limit in the company to 49...
    Lupin launches generic conjunctivitis treatment medicine in US

    Lupin launches generic conjunctivitis treatment medicine in US

    Ruby Khatun Khatun6 July 2017 12:59 PM IST
    New Delhi: Domestic pharma major Lupin Ltd on Wednesday said it has launched in the US market its generic version of Moxifloxacin Hydrochloride...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok